Compartir, , Google Plus, Pinterest,

Posted in:

ERA-NET. TRANSCAN-2.

 Immunology and immunotherapy of cancer: strengthening the translational aspects

Fecha de publicación: 4 de Diciembre de 2015
Fecha de cierre: 5 de Febrero de 2016
Financiación: 250.000 €

The ERA-NET: Aligning national/regional translational cancer research programmes and activities (TRANSCAN-2) is the continuation of the ERA-NET on Translational Cancer Research (TRANSCAN) and has the goal of coordinating national and regional funding programmes for research in the area of translational cancer research. The specific challenge is to promote a transnational collaborative approach between scientific teams in demanding areas of translational cancer research while avoiding the duplication of efforts and ensuring a more efficient use of available resources, to produce significant results of higher quality and impact, and share data and infrastructures. Along this line TRANSCAN-2 will launch the Joint Transnational Call for research proposals (JTC 2015) in December 2015.

Más información